Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Natalie M. Bath"'
Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
Autor:
Sandesh Parajuli, Natalie M. Bath, Luis Hidalgo, Glen Leverson, Neetika Garg, Robert R. Redfield III, Didier A. Mandelbrot
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1508-1519 (2021)
Abstract Background The effect of low‐level pretransplant donor‐specific antibody (DSA) on kidney transplant outcomes is not well described. The goal of this study was to compare outcomes among patients of varying immunologic risk, based on the l
Externí odkaz:
https://doaj.org/article/6d8e7127d34947fd8e3f06d8138864c9
Autor:
Bret M. Verhoven, BS, Aos S. Karim, MD, Natalie M. Bath, MD, Carol J. Sarabia Fahl, MS, Nancy A. Wilson, PhD, Robert R. Redfield, III, MD, William E. Fahl, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 8, p e578 (2020)
Background. Ischemia-reperfusion injury, including injury from warm- and cold-ischemia (CI) organ storage, remains a significant problem for all solid organ transplants. Suppressing CI damage would reduce delayed graft function and increase the donor
Externí odkaz:
https://doaj.org/article/3702a247a1fe464395149b7e4a13e8cd
Autor:
Natalie M Bath, Xiang Ding, Nancy A Wilson, Bret M Verhoven, Brittney A Boldt, Adarsh Sukhwal, Shannon R Reese, Sarah E Panzer, Arjang Djamali, Robert R Redfield
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211865 (2019)
Alloantibody represents a significant barrier in kidney transplant through the sensitization of patients prior to transplant through antibody mediated rejection (ABMR). APRIL BLyS are critical survival factors for mature B lymphocytes plasma cells, t
Externí odkaz:
https://doaj.org/article/029b107867da4ec9ba34a04f8fdd2243
Autor:
Natalie M Bath, Xiang Ding, Bret M Verhoven, Nancy A Wilson, Lauren Coons, Adarsh Sukhwal, Weixiong Zhong, Robert R Redfield Iii
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223889 (2019)
Chronic antibody mediated rejection (cAMR) remains a significant barrier to achieving long-term graft survival in kidney transplantation, which results from alloantibody production from B lymphocytes and plasma cells. APRIL (A proliferation-inducing
Externí odkaz:
https://doaj.org/article/14aeae110b9649bda5b3024ae64baff4
Autor:
Natalie M. Bath, Angela Sarna, Marilly Palettas, Christina Monsour, Lena Stevens, Heena Santry, Aslam Ejaz, Alex Kim, Timothy Pawlik, Jordan M. Cloyd
Publikováno v:
Journal of Surgical Oncology.
Autor:
Coen L. Klos, Natalie M. Bath, Evie Carchman, Glen Leverson, Elise Lawson, Cristina B. Sanger, Ray King, Charles Heise
Publikováno v:
Colorectal Disease.
Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
Autor:
Natalie M. Bath, Neetika Garg, Robert R. Redfield, Sandesh Parajuli, Glen Leverson, Didier A. Mandelbrot, Luis G. Hidalgo
Publikováno v:
Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1508-1519 (2021)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease
Background The effect of low‐level pretransplant donor‐specific antibody (DSA) on kidney transplant outcomes is not well described. The goal of this study was to compare outcomes among patients of varying immunologic risk, based on the level of p
Autor:
Luis G. Hidalgo, Thomas Ellis, Robert R. Redfield, Natalie M. Bath, Jillian L. Descourouez, Dave Hager, Arjang Djamali, Glen Leverson, Sandesh Parajuli, Dixon B. Kaufman, Didier A. Mandelbrot, Margaret R. Jorgenson
Publikováno v:
Kidney360
BACKGROUND: Optimal induction for patients without pretransplant donor-specific antibodies (DSAs) is poorly defined. The goal of this study was to compare the incidence of de novo DSA (dnDSA) and graft outcomes between induction therapies in patients
Autor:
David P. Foley, Glen Leverson, Anthony M. D’Alessandro, David P. Al-Adra, Joshua D. Mezrich, Natalie M. Bath
Publikováno v:
Liver Transplantation. 26:1127-1137
The acceptable threshold remains unknown for the percentage of macrosteatosis (MaS) and microsteatosis (MiS) to yield optimal outcomes after donation after circulatory death (DCD) liver transplantation (LT). The purpose of this analysis was to determ
Publikováno v:
Experimental and Clinical Transplantation. 18:300-305
Objectives Nutcracker syndrome is rare, and a proportion of patients with this syndrome continue to have intractable pain and symptoms. Due to the heterogeneity of patients' chief complaints and symptoms, the surgeon's preferred approach may be inher